Congress trades in Supernus Pharmaceuticals (SUPN)
Healthcare · Drug Manufacturers - Specialty & Generic
1 member of Congress has disclosed 4 trades in Supernus Pharmaceuticals (SUPN) since 2025: 3 buys and 1 sale. The most recent was disclosed on Apr 8, 2026.
- Trades disclosed
- 4
- Members trading
- 1
- Buys / sells
- 3 / 1
- Reported value
- $4K–$60K
Who traded SUPN
- Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)3 buys · 1 sale31Apr 8, 2026
All trades
- Apr 8, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Supernus Pharmaceuticals SUPN
$1K–$15K · Traded Mar 3, 2026 · disclosed Apr 8, 2026
- Jan 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Supernus Pharmaceuticals SUPN
$1K–$15K · Traded Dec 11, 2025 · disclosed Jan 12, 2026
- Nov 18, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold (partial) Supernus Pharmaceuticals SUPN
$1K–$15K · Traded Oct 9, 2025 · disclosed Nov 18, 2025
- Apr 7, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Supernus Pharmaceuticals SUPN
$1K–$15K · Traded Mar 24, 2025 · disclosed Apr 7, 2025
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.